For research use only. Not for use in humans.

Bevacizumab (anti-VEGF)

Synonyms: rhuMab VEGF Cat.No.A2006 Purity:98.95%

Bevacizumab (anti-VEGF, Avastin) is a humanized anti-VEGF monoclonal antibody which binds to and neutralizes all human VEGF-A isoforms and bioactive proteolytic fragments, MW:149 KD.

Click to purchase the isotype control of

48 Citations

17 Nobel Prize winners
have used Selleck products

Shimon Sakaguchi

Nature Communications 2025;16, Article number:1325

David Baker

Dev Cell 2023;58(20):2163-2180.e9.

Michael Houghton

Cell Chem Biol 2020;27(7):780-792.e5

David Julius

Cell 2017;185-198.e16

Charles M. Rice

Cell 2018;172(3):423-438.e25

Quality Control

Batch: Purity: 98.95% Protein concentration: 4.94mg/ml Endotoxin Level: ≤1 EU/mg

98.95

Specificity

Name	Citation	VEGFR1	VEGFR2	VEGFR3	Others
Foretinib	94	+++	++++	++++	Met,Tie-2,RON
Cediranib (AZD2171)	67	+++	++++	++++	c-Kit,PDGFRβ,FGFR1
PD173074	124		+		FGFR1
Dovitinib (TKI-258)	52	+++	+++	+++	FLT3,c-Kit,FGFR1
Linifanib (ABT-869)	33	++++	++++	+	CSF-1R,FLT3,Kit
Vatalanib (PTK787) 2HCl	53	+	++	+	PDGFRβ,c-Kit,c-Fms
RAF265 (CHIR-265)	24		++		B-Raf
Motesanib Diphosphate (AMG-706)	12	++++	++++	+++	Kit,RET,PDGFR
Brivanib (BMS-540215)	10	+	++		FGFR1
MGCD-265 analog	12	++++	++++	++++	Met,RON,Tie-2
AEE788 (NVP-AEE788)	13	+	+		EGFR,HER2/ErbB2,c-Abl
ENMD-2076	9		+	++	FLT3,RET,Aurora A
OSI-930	7	+++	+++		CSF-1R,LCK,C-Raf
CYC116	10		++		Aurora A,Aurora B,FLT3
Ki8751	21		++++		c-Kit,PDGFRα
Telatinib	5		+++	++++	c-Kit,PDGFRα
KRN 633	6	+	+	+	PDGFRα,c-Kit,BTK
SAR131675	34			++
Apatinib (YN968D1) mesylate	26		++++		RET
BMS-794833	2		++		Met
Brivanib Alaninate (BMS-582664)	2	+	++		FGFR1
Golvatinib (E7050)	8		++		c-Met
Semaxanib (SU5416)	21		+
ZM 323881 HCl	20		++++
ZM 306416	13	+			Src,Abl
Sitravatinib (MGCD516)	7	+++	+++	++++	DDR2,EPHA3,Axl
BFH772	0		++++
BAW2881 (NVP-BAW2881)	3	+	+++	+	C-Raf-1,B-RAFV599E,c-Abl
SU 5402	24		++		FGFR1,PDGFRβ
Dovitinib (TKI258) Lactate monohydrate	31	+++	+++	+++	FLT3,c-Kit,FGFR1
LY2874455	15		+++		FGFR2,FGFR1,FGFR4
SKLB1002	5		++
AZD2932	3		+++		PDGFRβ,Flt3,c-Kit

Expand to Check More

1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation.
2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description	Bevacizumab (anti-VEGF, Avastin) is a humanized anti-VEGF monoclonal antibody which binds to and neutralizes all human VEGF-A isoforms and bioactive proteolytic fragments, MW:149 KD.
Features	Human IgG1
Targets/IC₅₀/Ki	VEGFR2 VEGF-A VEGF
In vitro	Blocking VEGF with bevacizumab reduces the proangiogenic effect of affected fibroblasts in both the matrigel and direct coculture Angiogenesis models.
Cell Research	Matrigel gels were created using low GF Matrigel (protein concentration > 9.5 mg/ml) in a 48-well plate. It was gelled at 37 ℃ overnight and then rinsed twice with PBS. endothelial cells (ECs) were added in 250 μl endothelial basal medium with no supplement and allowed to adhere for 1 hour. An additional 250 μl of 48 h conditioned medium from unaffected or affected fibroblasts or nonconditioned medium with or without 20 ng/ml VEGF and with or without 250 μl/ml bevacizumab in 5% FBS + 1% penicillin/streptomycin in DMEM was added, and ECs were incubated for 14 h before being fixed and stained for CD31. ECs network formation was also tracked by live-cell imaging at 2, 4, 8, 16, and 24 h.
In vivo	The combinational treatment of AAV9-LECT2-shRNA and bevacizumab significantly improves the therapeutic effects on liver fibrosis.
Animal Research	Animal Models: Male C57BL/6J mice of CCl4-induced fibrosis model Dosages: 2 mg/kg Administration: i.p. Reference: https://pubmed.ncbi.nlm.nih.gov/34940991/
References	[1] https://pubmed.ncbi.nlm.nih.gov/35189151/ [2] https://pubmed.ncbi.nlm.nih.gov/34940991/

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID

Product Details

CAS No.	216974-75-3
Isotype	Human IgG1
Source	CHO cells
Sterility	0.2 μM filtered
Formulation	PBS buffer, pH 7.2
Storage	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Comparison of Clones for

^*Literature analysis of various clone (for this target) products available on the market shows that Sellecks selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
How to store the antibody?

Answer:
Store the undiluted solution at 4 °C in the dark. Freezing antibodies can result in a loss of activity caused by the freezing/thawing process. Diluting antibodies to working concentrations and storing at 4°C for more than a day should be avoided. Additionally, make sure to keep the antibody sterile. Under these storage conditions, your antibodies should remain active for up to one year and oftentimes longer.